UV physics from IR features: new prospects from top flavor violation

New physics in the rare top decays $t \to q \ell^+\ell^-$ is currently very weakly constrained. We show that in a large class of Standard Model extensions, existing experimental constraints on new physics in flavor-conserving processes imply strong indirect bounds on new physics contributions to flavor-violating processes of the form $t \to q \ell^+\ell^-$. These indirect bounds arise from basic principles of quantum field theory together with a few generic conditions on the UV structure of the theory, and are roughly an order of magnitude stronger than the present experimental bounds on the same processes. These constraints provide a theoretically-motivated target for experimental searches for $t \to q \ell^+\ell^-$: violation of these bounds would exclude a large class of new physics models, and would provide nontrivial insight into the UV behavior of the new physics.Comment: 16 pages, 6 figure

Chinese Glaucoma Patients

This cross-sectional study evaluated VRQOL in Chinese glaucoma patients and the potential factors influencing VRQOL. The VRQOL was assessed using the Chinese-version low vision quality of life questionnaire. Visual field loss was classified by the Hodapp-Parrish-Anderson method. The correlations of VRQOL to the best corrected visual acuity and the VF loss were investigated. The potential impact factors to VRQOL of glaucoma patients were screened by single factor analysis and were further analyzed by multiple regression analysis. There were significant differences in VRQOL scores between mild VF loss group and moderate VF loss group, moderate VF loss group and severe VF loss group, and mild VF loss group and severe VF loss group according to the better eye. In multiple linear regression, the binocular weighted average BCVA significantly affected the VRQOL scores. Binocular MD was the second influencing factor. In logistic regression, binocular severe VF loss and stroke were significantly associated with abnormal VRQOL. Education was the next influencing factor. This study showed that visual acuity correlated linearly with VRQOL, and VF loss might reach a certain level, correlating with abnormal VRQOL scores. Stroke was significantly associated with abnormal VRQOL

Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery

The present study aimed at observing the effect of a single subconjunctival injection of bevacizumab (BVZ) combined with 5-fluorouracil (5-Fu) or mitomycin C (MMC) on the antiscarring effect of glaucoma filtration surgery (GFS). The inhibitory effect of combined BVZ and 5-Fu in retinal pigment epithelial cells on vascular endothelial growth factor (VEGF) levels was demonstrated through in vitro experiments. Combined BVZ and 5-Fu and combined BVZ and MMC inhibited cell cycle, induced apoptosis, and inhibited human umbilical vein endothelial cell migration. Also, the cytotoxicity of combined BVZ and 5-Fu was lower. In animal experiments, the observation of filtering bleb survival, hematoxylin and eosin and Masson staining of filtering bleb scars, and mRNA expression levels of fibrosis markers in filtering blebs showed that combined BVZ and 5-Fu had a better antiscarring effect compared with single drugs; however, the antiscarring effect of combined BVZ and MMC was not significantly different from MMC. Therefore, the findings of this study provided more reference for the clinical use of adjuncts to inhibit scarring after GFS and helped understand the regulatory effect of combined anti-VEGF antibody BVZ and antimetabolites on wound healing more comprehensively

Vision Health-Related Quality of Life in Chinese Glaucoma Patients

This cross-sectional study evaluated VRQOL in Chinese glaucoma patients and the potential factors influencing VRQOL. The VRQOL was assessed using the Chinese-version low vision quality of life questionnaire. Visual field loss was classified by the Hodapp-Parrish-Anderson method. The correlations of VRQOL to the best corrected visual acuity and the VF loss were investigated. The potential impact factors to VRQOL of glaucoma patients were screened by single factor analysis and were further analyzed by multiple regression analysis. There were significant differences in VRQOL scores between mild VF loss group and moderate VF loss group, moderate VF loss group and severe VF loss group, and mild VF loss group and severe VF loss group according to the better eye. In multiple linear regression, the binocular weighted average BCVA significantly affected the VRQOL scores. Binocular MD was the second influencing factor. In logistic regression, binocular severe VF loss and stroke were significantly associated with abnormal VRQOL. Education was the next influencing factor. This study showed that visual acuity correlated linearly with VRQOL, and VF loss might reach a certain level, correlating with abnormal VRQOL scores. Stroke was significantly associated with abnormal VRQOL

The Impact of Unilateral or Bilateral Cataract Surgery on Visual Acuity and Life Quality of Elderly Patients

In the current study, the CLVQOL was used to assess VRQOL before unilateral or bilateral cataract surgery and at the end of the follow-up period in order to determine the greater beneficial mode of surgery for patients, if one of the two surgical methods is more beneficial over the other. The patients were classified as receiving unilateral (group A) and bilateral cataract surgery (group B). There were no significant differences between groups A and B before the operation in terms of life quality scores, binocular weighted average LogMAR BCVA, age, educational level, gender, systematic and ocular comorbidities, and the complications of the operation. It was shown that visual acuity improved more significantly with bilateral cataract surgery than with unilateral surgery in elderly patients with a high preoperative disease burden in Shanghai city. However, the improvement in life quality was not different in patients receiving either bilateral or unilateral cataract surgery

Effects of In-Situ Reaction, Extrusion Ratio and CeO₂ on the Performance of Al-Ti-C-(Ce) Grain Refiners for Refining Pure Aluminum Grains

Al-Ti-C-(Ce) grain refiners were prepared by combining in-situ reaction, hot extrusion, and adding CeO2. The effects of second phase TiC particle size and distribution, extrusion ratio, and Ce addition on the grain-refining performance of grain refiners were investigated. The results show that about 10 nm TiC particles are dispersed on the surface and inside of 100–200 nm Ti particles by in-situ reaction. The Al-Ti-C grain refiners, which are made, by hot extrusion, of a mixture of in-situ reaction Ti/TiC composite powder and Al powder, increase the effective nucleation phase of α-Al and hinder grain growth due to the fine and dispersed TiC; this results in the average size of pure aluminum grains to decrease from 1912.4 μm to 504.8 μm (adding 1 wt.% Al-Ti-C grain refiner). Additionally, with the increase of the extrusion ratio from 13 to 30, the average size of pure aluminum grains decreases further to 470.8 μm. This is because the micropores in the matrix of grain refiners are reduced, and the nano-TiC aggregates are dispersed with the fragmentation of Ti particles, resulting in a sufficient Al-Ti reaction and an enhanced nucleation effect of nano-TiC. Furthermore, Al-Ti-C-Ce grain refiners were prepared by adding CeO2. Under the conditions of holding for 3–5 min and adding a 5.5 wt.% Al-Ti-C-Ce grain refiner, the average size of pure aluminum grains is reduced to 48.4–48.8 μm. The reason for the excellent grain-refining and good anti-fading performance of the Al-Ti-C-Ce grain refiner is presumedly related to the Ti2Al20Ce rare earth phases and [Ce] atoms, which hinder agglomeration, precipitation, and dissolution of the TiC and TiAl3 particles

Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19

COVID-19 is still prevalent around the globe. Although some SARS-CoV-2 vaccines have been distributed to the population, the shortcomings of vaccines and the continuous emergence of SARS-CoV-2 mutant virus strains are a cause for concern. Thus, it is vital to continue to improve vaccines and vaccine delivery methods. One option is nasal vaccination, which is more convenient than injections and does not require a syringe. Additionally, stronger mucosal immunity is produced under nasal vaccination. The easy accessibility of the intranasal route is more advantageous than injection in the context of the COVID-19 pandemic. Nanoparticles have been proven to be suitable delivery vehicles and adjuvants, and different NPs have different advantages. The shortcomings of the SARS-CoV-2 vaccine may be compensated by selecting or modifying different nanoparticles. It travels along the digestive tract to the intestine, where it is presented by GALT, tissue-resident immune cells, and gastrointestinal lymph nodes. Nasal nanovaccines are easy to use, safe, multifunctional, and can be distributed quickly, demonstrating strong prospects as a vaccination method for SARS-CoV-2, SARS-CoV-2 variants, or SARS-CoV-n